BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Wednesday, March 18, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 5, 2012
View Archived Issues
Dalcetrapib continues to show positive effects on HDL cholesterol
Read More
Characterization of new ApoA-I formulation presented at different meetings
Read More
Aeterna Zentaris presents promising compound for cancer treatment
Read More
Astellas Pharma discloses new phosphodiesterase 9A inhibitors
Read More
New EthR inhibitor enhances antimycobacterial activity of ethionamide
Read More
Discovery and entry of ABT-199 into clinic reported at AACR meeting
Read More
University of Pittsburgh synthesizes new p53/Mdm2 antagonists
Read More
Novel microRNA-based tests classify tumor types with high accuracy
Read More
LabCorp licenses diagnostic technology for Alzheimer's disease
Read More
FDA extends review of Lymphoseek
Read More
GTx replies to FDA's clinical hold letter regarding Capesaris
Read More
Fresenius Medical Care gains marketing rights to TRK-820
Read More
Genzyme submits mipomersen NDA in U.S.
Read More
BLA submission completed for metreleptin
Read More
New recombinant therapy enters phase I trial in coronary artery disease
Read More
Xencor receives milestone payment from Boehringer Ingelheim
Read More
Hanmi Pharmaceutical's HM-47000 selected as a government project
Read More
Preclinical development of antibiotic completed
Read More
Sclerostin-directed antibody advances to phase III for osteoporosis
Read More
Shin Nippon Biomedical reports phase I data on intranasal zolmitriptan
Read More
New metabotropic glutamate mGlu5 receptor modulators designed
Read More
Novel BTK inhibitors reported
Read More
Takeda presents novel cognition-enhancing products
Read More
Trillium provides update on lead cancer program
Read More
FDA grants priority review to Zaltrap BLA
Read More
Mercury Pharma combination therapy approved in Scotland
Read More
Newron and Zambon provide update on safinamide
Read More
